GlassScriptPhysician profile
Endia Boyd
NPI 1750851937
$596.24
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $163.53 | 2023 | |
| Lilly USA, LLC | $150.80 | 2023 | Mounjaro |
| Novo Nordisk INC | $51.92 | 2023 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.79 | 2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $40.24 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $33.28 | 2023 | Farxiga |
| Amgen INC. | $27.15 | 2023 | Repatha, Otezla |
| Xeris Pharmaceuticals, INC. | $23.38 | 2023 | Gvoke Hypopen |
| Dexcom, INC. | $18.37 | 2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $14.71 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $13.10 | 2023 | |
| Idorsia Pharmaceuticals US INC | $12.97 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Endia Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.